$CRVW
CareView Communications Inc Stock $crvw

$crvw Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000143774924026690 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q4
Revenue	$1.932M	$1.974M	$1.767M
YoY Change	-20.33%	-46.8%	-7.88%
Cost Of Revenue	$905.4K	$640.7K	$740.0K
YoY Change	67.66%	-16.08%	101.55%
Gross Profit	$1.027M	$1.333M	$1.027M
YoY Change	-45.66%	-54.76%	-33.78%
Gross Profit Margin	53.15%	67.54%	58.12%
Selling, General & Admin	$1.051M	$1.026M	$1.017M
YoY Change	-5.16%	-20.01%	7.08%
% of Gross Profit	102.32%	76.98%	99.0%
Research & Development	$593.7K	$515.2K	$847.0K
YoY Change	-4.54%	-0.03%	189.85%
% of Gross Profit	57.81%	38.65%	82.48%
Depreciation & Amortization	$61.01K	$63.46K	$62.01K
YoY Change	-32.21%	-38.35%	-54.91%
% of Gross Profit	5.94%	4.76%	6.04%
Operating Expenses	$2.617M	$2.293M	$1.975M
YoY Change	5.99%	-20.68%	20.99%
Operating Profit	-$684.5K	-$319.1K	-$948.1K
YoY Change	1472.24%	-138.92%	1062.16%
Interest Expense	-$786.2K	-$788.2K	-$668.2K
YoY Change	-194.61%	-191.06%	-40.58%
% of Operating Profit
Other Income/Expense, Net	-$786.2K	-$788.2K
YoY Change	-4.86%	-8.82%
Pretax Income	-$1.471M	-$1.107M	-$1.616M
YoY Change	69.06%	2371.2%	-670.37%
Income Tax	$0.00	$0.00	$74.52K
% Of Pretax Income
Net Earnings	-$1.471M	-$1.107M	-$1.691M
YoY Change	69.06%	2371.2%	-696.67%
Net Earnings / Revenue	-76.11%	-56.1%	-95.69%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	583.9M	583.9M	583.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.400M	$1.739M	$1.146M
YoY Change	109.01%	145.85%	120.29%
Cash & Equivalents	$1.400M	$1.739M	$1.146M
Short-Term Investments
Other Short-Term Assets	$368.2K	$437.3K	$335.1K
YoY Change	11.62%	-2.08%	371.82%
Inventory	$317.3K	$309.4K	$294.4K
Prepaid Expenses			$62.84K
Receivables	$997.0K	$1.343M	$1.168M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.083M	$3.829M	$2.943M
YoY Change	0.67%	15.62%	59.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$191.0K	$238.8K	$610.6K
YoY Change	-49.15%	-46.92%	-4.97%
Goodwill
YoY Change
Intangibles	$408.6K	$408.0K	$406.3K
YoY Change	-44.7%	-45.56%	-50.46%
Long-Term Investments
YoY Change
Other Assets	$294.1K	$350.0K	$302.0K
YoY Change	8.93%	76.17%	-79.37%
Total Long-Term Assets	$1.065M	$1.210M	$1.319M
YoY Change	-37.94%	-31.42%	-37.39%
TOTAL ASSETS
Total Short-Term Assets	$3.083M	$3.829M	$2.943M
Total Long-Term Assets	$1.065M	$1.210M	$1.319M
Total Assets	$4.148M	$5.039M	$4.262M
YoY Change	-13.2%	-0.73%	7.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$427.2K	$436.1K	$598.1K
YoY Change	-29.48%	-24.22%	-8.1%
Accrued Expenses	$19.48M	$18.78M	$17.10M
YoY Change	18.35%	20.31%	24.08%
Deferred Revenue
YoY Change
Short-Term Debt	$700.0K	$700.0K	$700.0K
YoY Change	0.0%	0.0%	0.0%
Long-Term Debt Due	$20.00M	$20.00M	$20.00M
YoY Change	0.0%	-1.28%	-60.0%
Total Short-Term Liabilities	$43.35M	$43.12M	$40.21M
YoY Change	11.09%	11.8%	-39.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$287.1K	$52.77K	$318.0K
YoY Change	89.95%	223.37%	1254.33%
Total Long-Term Liabilities	$287.1K	$99.08K	$318.0K
YoY Change	-14.15%	-59.12%	-97.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$43.35M	$43.12M	$40.21M
Total Long-Term Liabilities	$287.1K	$99.08K	$318.0K
Total Liabilities	$43.64M	$43.22M	$40.52M
YoY Change	10.88%	11.36%	-49.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$211.5M	-$210.0M	-$207.9M
YoY Change	2.57%	2.28%	1.94%
Common Stock	$583.9K	$583.9K	$171.6M
YoY Change	0.0%	0.0%	34.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$39.49M	-$38.18M	-$36.26M
YoY Change
Total Liabilities & Shareholders Equity	$4.148M	$5.039M	$4.262M
YoY Change	-13.2%	-0.73%	7.97%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q4
OPERATING ACTIVITIES
Net Income	-$1.471M	-$1.107M	-$1.691M
YoY Change	69.06%	2371.2%	-696.67%
Depreciation, Depletion And Amortization	$61.01K	$63.46K	$62.01K
YoY Change	-32.21%	-38.35%	-54.91%
Cash From Operating Activities	-$356.4K	$619.8K	$533.6K
YoY Change	1087.87%	128.86%	-709.91%
INVESTING ACTIVITIES
Capital Expenditures	-$19.93K	$128.1K	$6.790K
YoY Change	-299.3%	6501.03%	-111.65%
Acquisitions
YoY Change
Other Investing Activities			-$45.68K
YoY Change
Cash From Investing Activities	$19.93K	-$128.1K	-$52.47K
YoY Change	-299.3%	6501.03%	-190.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.170K	-2.350K	-5.440K
YoY Change		-33.24%	-102.09%
NET CHANGE
Cash From Operating Activities	-356.4K	619.8K	533.6K
Cash From Investing Activities	19.93K	-128.1K	-52.47K
Cash From Financing Activities	-2.170K	-2.350K	-5.440K
Net Change In Cash	-338.6K	489.4K	475.7K
YoY Change	746.5%	84.43%	105.64%
FREE CASH FLOW
Cash From Operating Activities	-$356.4K	$619.8K	$533.6K
Capital Expenditures	-$19.93K	$128.1K	$6.790K
Free Cash Flow	-$336.4K	$491.8K	$526.8K
YoY Change	741.08%	82.89%	-1902.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	583880748
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	583880748
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	583880748
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	583880748
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P0Y6M
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-54090
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4659068
	dei	Entity Address Address Line1 EntityAddressAddressLine1	405 State Highway 121, Suite B-240
	dei	Entity Address City Or Town EntityAddressCityOrTown	Lewisville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75067
	dei	City Area Code CityAreaCode	972
	dei	Local Phone Number LocalPhoneNumber	943-6050
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	CRVW
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	583880748
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1738994	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1145871	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1342847	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1167934	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	309371	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	294435	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	437341	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	335091	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	3828553	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2943331	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	238794	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	317626	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	407983	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	406301	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	213317	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	292990	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	350038	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	302010	usd
CY2024Q2	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	971338	usd
CY2023Q4	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	1001301	usd
CY2024Q2	us-gaap	Assets Assets	5038685	usd
CY2023Q4	us-gaap	Assets Assets	4262258	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	436125	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	598095	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3150192	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1752061	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	193634	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	188184	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	18083389	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	16479139	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	556789	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	489497	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	43120129	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	40206976	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46311	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	139099	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	52771	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	178907	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	99082	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	318006	usd
CY2024Q2	us-gaap	Liabilities Liabilities	43219211	usd
CY2023Q4	us-gaap	Liabilities Liabilities	40524982	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	583881	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	583881	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	171250044	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	171038349	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-210014451	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-207884954	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-38180526	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-36262724	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5038685	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4262258	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1973639	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3710109	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4176878	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5492368	usd
CY2024Q2	us-gaap	Equipment Expense EquipmentExpense	42460	usd
CY2023Q2	us-gaap	Equipment Expense EquipmentExpense	224997	usd
	us-gaap	Equipment Expense EquipmentExpense	91644	usd
	us-gaap	Equipment Expense EquipmentExpense	256929	usd
CY2024Q2	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	640685	usd
CY2023Q2	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	763487	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	1483986	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	1468530	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	789509	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1051953	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1407293	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1749720	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	236533	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	230814	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	564217	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	399233	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	515234	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	515374	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1042709	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1034006	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	68271	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	103797	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	139468	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	280628	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	2292692	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2890422	usd
	us-gaap	Operating Expenses OperatingExpenses	4729317	usd
	us-gaap	Operating Expenses OperatingExpenses	5189046	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-319053	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	819687	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-552439	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	303322	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	802125	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	865627	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1604250	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1696961	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	13907	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1133	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	27192	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2020	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-788218	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-864494	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1577058	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1694941	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1107271	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-44807	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2129497	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1391619	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1107271	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-44807	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2129497	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1391619	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	583880748
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	463880748
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	583880748
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	304336304
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-76660729	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	62260	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	26200000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1346812	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-51745281	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	54796	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	18000000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-44807	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-33735292	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-36262724	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	53271	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1022226	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-37231679	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	158424	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1107271	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-38180526	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2129497	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1391619	usd
	us-gaap	Depreciation Depreciation	108710	usd
	us-gaap	Depreciation Depreciation	194619	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20577	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	70697	usd
	crvw	Amortization Of Deferred Installation Costs AmortizationOfDeferredInstallationCosts	10182	usd
	crvw	Amortization Of Deferred Installation Costs AmortizationOfDeferredInstallationCosts	15312	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	79674	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	67859	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	211695	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	117056	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	174913	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1061428	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14936	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-153773	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	102250	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	375601	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-161970	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-75286	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1604250	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1604250	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	67292	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	481398	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1286061	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	480156	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-31794	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	12550	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-87338	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-72352	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	749331	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	196284	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29878	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1943	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	120459	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-150337	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1943	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5871	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7162	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5871	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7162	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	593123	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	187179	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1145871	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	520166	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1738994	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	707345	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	44200000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4176878	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5492368	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3200792	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1877116	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1323676	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3200792	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	48309	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	33461	usd
	crvw	Capitalized Contract Cost Additions CapitalizedContractCostAdditions	98200	usd
	crvw	Capitalized Contract Cost Additions CapitalizedContractCostAdditions	0	usd
	crvw	Capitalized Contract Cost Expense Recognized CapitalizedContractCostExpenseRecognized	10181	usd
	crvw	Capitalized Contract Cost Expense Recognized CapitalizedContractCostExpenseRecognized	15312	usd
CY2024Q2	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	136328	usd
CY2023Q2	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	18149	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	73621280
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	46711922
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	73621280
CY2024Q2	crvw	Working Capital Deficit WorkingCapitalDeficit	39291576	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5694445
CY2023	crvw	Class Of Warrant Or Right Weighted Average Remaining Contractual Life ClassOfWarrantOrRightWeightedAverageRemainingContractualLife	P2Y7M6D
CY2024Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5694445
	crvw	Class Of Warrant Or Right Weighted Average Remaining Contractual Life ClassOfWarrantOrRightWeightedAverageRemainingContractualLife	P2Y1M6D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	30277858
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	1816521
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.06
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	38483977
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.09
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	314925	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	30277858
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.06
	crvw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Life SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualLife	P9Y4M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	835000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.58
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	67926835
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.07
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	104475	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	36718977
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.08
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y8M12D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	104475	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	211695	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	117056	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1663565	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M6D
CY2024Q2	us-gaap	Prepaid Insurance PrepaidInsurance	304005	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	180267	usd
CY2024Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	41355	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	62843	usd
CY2024Q2	us-gaap	Prepaid Taxes PrepaidTaxes	91981	usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	91981	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	437341	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	335091	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	309371	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	294435	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9956331	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9926453	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9717537	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9608827	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	238794	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	317626	usd
	us-gaap	Depreciation Depreciation	108710	usd
	us-gaap	Depreciation Depreciation	194619	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	921989	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	514006	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	407983	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	899729	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	493428	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	406301	usd
CY2024Q2	crvw	Other Noncurrent Assets Gross OtherNoncurrentAssetsGross	2345507	usd
CY2024Q2	crvw	Other Noncurrent Assets Accumulated Amortization OtherNoncurrentAssetsAccumulatedAmortization	1995469	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	350038	usd
CY2023Q4	crvw	Other Noncurrent Assets Gross OtherNoncurrentAssetsGross	2133064	usd
CY2023Q4	crvw	Other Noncurrent Assets Accumulated Amortization OtherNoncurrentAssetsAccumulatedAmortization	1831054	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	302010	usd
CY2024Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	54802	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	54802	usd
CY2024Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	129221	usd
CY2023Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	164566	usd
CY2024Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	49528	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	49528	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	323238	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	220601	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	556789	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	489497	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	151900	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	147894	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	112168	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	150679	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	262847	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	22902	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	239945	usd

Files In Submission

Name	View Source	Status
0001437749-24-026690-index-headers.html	Edgar Link	pending
0001437749-24-026690-index.html	Edgar Link	pending
0001437749-24-026690.txt	Edgar Link	pending
0001437749-24-026690-xbrl.zip	Edgar Link	pending
crvw-20240630.xsd	Edgar Link	pending
crvw20240331_10qimg001.jpg	Edgar Link	pending
crvw20240630_10q.htm	Edgar Link	pending
ex_697931.htm	Edgar Link	pending
ex_697932.htm	Edgar Link	pending
ex_697933.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
crvw-20240630_def.xml	Edgar Link	unprocessable
crvw-20240630_lab.xml	Edgar Link	unprocessable
crvw-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
crvw20240630_10q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
crvw-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRVW
CareView Communications Inc Stock $crvw

2024 Q3 Form 10-Q Financial Statement

#000143774924026690 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRVW CareView Communications Inc Stock $crvw

2024 Q3 Form 10-Q Financial Statement

#000143774924026690 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRVW
CareView Communications Inc Stock $crvw